Aardvark Therapeutics Inc (AARD)

SG&A Expenses

$4.63M

Quarterly · Period ending: · USD

AARD logo

AARD SG&A Expenses

Latest reported$4.63M
AARD Quarterly SG&A Expenses ($538.00K → $4.63M)
High-resolution chart · PNG

AARD sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aardvark Therapeutics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
4,629,000
5,897,000
4,405,000
3,966,000
2,703,000
2,715,000
1,388,000
1,026,000
2,030,000
861,000
525,000
538,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.